Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation Ian WadsworthThomas JakiLisa V. Hampson Current Opinion Open access 13 September 2016 Pages: 1011 - 1017
May the Force Be With You: The Light and Dark Sides of the Microbiota–Gut–Brain Axis in Neuropsychiatry Eoin SherwinKiran V. SandhuJohn F. Cryan Leading Article Open access 14 July 2016 Pages: 1019 - 1041
Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials Kim S. J. LaoYing HeEsther W. Chan Systematic Review 22 August 2016 Pages: 1043 - 1054
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond Wolfgang LöscherMichel GillardHenrik Klitgaard Review Article Open access 17 October 2016 Pages: 1055 - 1077
Novel Levodopa Formulations for Parkinson’s Disease Maria Eliza FreitasMarta Ruiz-LopezSusan H. Fox Review Article 14 October 2016 Pages: 1079 - 1095
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study Janet SultanaAndrea FontanaGianluca Trifirò Original Research Article 16 July 2016 Pages: 1097 - 1109
Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis Richard C. ChouMichael KaneJiang Gui Original Research Article 28 July 2016 Pages: 1111 - 1120
